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Introduction
Insulin resistance and glucose intolerance are frequent in
obese children and adolescents and  lead to a significant risk
for hypertension and cardiovascular diseases, as well as for
type 2 diabetes (1,2,3,4). The development of type 2 diabetes
mellitus is induced by the decreased insulin sensitivity, which
leads to increased insulin production. This imbalance causes
a predisposition to several metabolic disorders such as early
atherosclerosis, progressive obesity, acanthosis nigricans,
increase in skin tags, hypertension, dyslipidemia, fatty 
liver and polycystic ovarian syndrome (5). Obesity and insulin
resistance, previously considered as a problem of older ages,
are becoming  serious issue also in the pediatric age group.
Early detection of insulin resistance is important for prevention
of these complications.
Various methods to define insulin sensitivity have been
developed. Among other models, euglycemic clamp and 
modified minimal model are considered to be gold standards.
However, they are complex and invasive tests, which can be
used  for research purposes only (6,7). Oral glucose tolerance
test (OGTT) has been shown to be as reliable as a frequently
sampled intravenous glucose tolerance test (FSIVGTT ) and a
clamp test in determining insulin sensitivity (8,9). However,
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methods such as fasting insulin level, fasting glucose/insulin
ratio (FGIR), homeostasis model assessment for insulin 
resistance  (HOMA-IR) and quantitative insulin-sensitivity
check index (QUICKI) are frequently used in population
screening  (7,10,11,12). HOMA-IR was found to be much
more reliable than FGIR and QUICKI in determining insulin
resistance in obese children (13). HOMA-IR is a frequently
used parameter in clinical research (12,14). 
Studies have shown that a physiological transient insulin
resistance develops in the pubertal period although its 
cause is not fully understood. Despite the fact that HOMA-IR
cut-off limit for insulin resistance is accepted as 2.5 in
adults,  corresponding values in prepubertal and pubertal
children and adolescents have not been reported (10). It is
known that the frequency of insulin resistance varies between
genders and also among races (15,16,17,18,19,20). However,
to our knowledge, there are no studies   defining cut-off levels
for HOMA-IR in children of prepubertal and pubertal ages
(14,21,22,23). 
The aim of the present study was to determine HOMA-IR
cut-off values in obese children and adolescents according
to gender and pubertal status.   
Methods
Two hundred and sixty eight obese children and 
adolescents (141 girls, 127 boys) aged between 5 and 18
years were included in the study. All patients had presented
with obesity to the Pediatric Endocrinology Clinic at Erciyes
University, Faculty of Medicine. Those with an underlying
endocrinologic disease or/and those under medication 
were excluded from the study. The children included in the
study had normal thyroid function tests and morning fasting
cortisol levels. Ethical approval was obtained from the 
Institutional Review Board of Erciyes University, Faculty of
Medicine. Parental consent was taken for additional blood
sampling to determine insulin levels. Body mass index
(BMI) of the patients was calculated using the equation:
BMI = Body weight (Kg)/Height (m)2. Subjects, whose BMI
values were above the 95th percentile of the BMI reference
curve adjusted to Turkish children according to age and 
gender, were accepted as obese (24). Detailed history 
was taken from the parents, and the subjects underwent a
detailed physical examination and pubertal evaluation 
performed by the same pediatric endocrinologist. A testicular
volume equal to or greater than 4 ml in boys and onset of
breast development in girls were accepted as the criteria
for onset of puberty.  
OGTT was carried out in order to determine insulin 
resistance. Following a 3-day high carbohydrate diet (300 g
/day) and overnight fasting, an oral dose of 1.75 g/kg 
(maximum 75 g) glucose was given, and blood samples 
were taken at 0, 30, 60, 90 and 120 minutes from a venous
catheter for glucose and insulin assessments (25,26). 
A total (the sum of insulin levels at 0, 30, 60, 90, and 120 
minutes during the OGTT) insulin level exceeding 
300 μU/mL was taken as hyperinsulinemia.  This method
was first introduced by Maruhama at al (25). The main reason
for selecting this criterion for hyperinsulinemia was to 
determine a cut-off for HOMA-IR as an index of insulin 
resistance. At each point in OGTT, both glucose and insulin
levels were measured, and then, total insulin levels 
exceeding 300 μU/mL were recorded as hyperinsulinemia.
Glucose levels at 120th minute were taken as a criterion for
impaired glucose tolerance or diabetes mellitus. HOMA-IR
was calculated using the equation: HOMA-IR=Fasting 
insulin (μU/mL) x Fasting glucose (mg/dL) /405 (10). 
Biochemical Analysis
Plasma glucose levels were measured by the glucose
oxidase method and the modified Trinder color reaction 
catalyzed by the peroxidase enzyme. Insulin levels were
measured with a immunoradiometric assay kit (INS-Irma 
Biosource, Nivelles, Belgium). The assay detection limit
was 1 μU/mL, and intra- and interassay coefficients of 
variation were 2.2% and 6.5%, respectively.  
Statistical Analysis
All statistical analyses were carried out using the Statistical
Package for Social Sciences (SPSS version 15.0 for 
Windows, Chicago, IL) and MedCalc (version 7.4.1.1, 
written by Frank Schoonjans, Mariakerke, Belgium). For 
the diagnosis of insulin resistance, HOMA-IR values were
obtained with the receiver operating characteristic (ROC)
analysis. Total insulin values exceeding 300 μU/mL during
the OGTT were accepted as insulin resistance, and ROC
analysis was undertaken to determine HOMA-IR cut-off 
values accordingly. ROC analysis is used to assess the actual
correctness of research results. Among the terms used in
this analysis, sensitivity is the ratio of patients with positive
results  (TP) to the number of patients, while specificity is
the ratio of healthy individuals with negative results (TN) to 
the number of healthy individuals (27). ROC analysis is a
standard approach used for determining the sensitivity and
specificity of the diagnostic procedure. ROC curves to find
out the relationship between the sensitivity and specificity
of the diagnosis are used for this purpose. The curves are
between the limits 0 and 1, and while proximity to the y 
coordinate and the upper limit shows a successful test, 
curves with slopes like 45o show a failed test. Thus, the 
success of the test can be evaluated by examining the 
ROC curves. In a successful test, the area under the curve
is expected to be great.
For comparisons between those with and without insulin
resistance, the Student t-test was used in parametric groups
and Mann-Whitney U test in non-parametric groups. Level
of significance was accepted as p<0.05. 
Results 
Forty-six boys (46.2%) were evaluated as prepubertal
and 81 (63.8%) as pubertal. Of the girls, 36 (25.5%) were
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the prepubertal groups, the mean age was 8.9±1.8 years in
boys and 8.3±1.4 years in girls, and the mean BMI was
28.2±5.4 kg/m2 in boys and 26.2±5.8 kg/m2 in girls. In the
pubertal groups, the mean age was 13.6±1.6 years in boys
and 13.2±2.0 years in girls, and the mean BMI 
was 30.9±4.9 kg/m2 in boys and 30.4±5.0 kg/m2 in girls.
Chronological ages, BMI values, fasting blood sugar and 
insulin values, blood sugar and insulin values at 120 
minutes, total insulin values measured during OGTT, FGIR
and HOMA-IR values calculated according to gender and
pubertal status are given in Tables 1 and 2.  
Following OGTT, the rate of insulin resistance in the 
prepubertal period was 37% (n=17) in boys and 27.8%
(n=10) in girls. In the pubertal children, these rates were
61.7% (n=50) in boys and 66.7% (n=70) in girls. 
When the groups were separated as those with and 
without insulin resistance, there were no differences regarding
age and BMI values, except for the girls in the pubertal 
period (Tables 1,2). 
We also compared the hyperinsulinemic and 
nonhyperinsulinemic groups for blood glucose levels at 
0 and 120thminutes of OGTT. We could not find any difference
in pre- and post-prandial blood glucose level in boys neither
in the prepubertal nor in the pubertal groups. In prepubertal
girls, we could not find any difference in fasting blood 
glucose level, but detected  a difference in the 120-minute
glucose level. In pubertal girls, there was a significant 
difference between 0- and 120-minute blood glucose levels
between insulin resistant and nonresistant groups (Table 2). 
HOMA-IR, fasting and 120-minute insulin values, FGIR
and total insulin values were significantly different between
the subjects of both sexes with and without insulin resistance
both in the prepubertal and pubertal groups (Tables 1, 2).
HOMA-IR cut-off values for insulin resistance were 
calculated to be 2.67 (sensitivity 88.2%, specificity 65.5%) in
boys and 2.22 (sensitivity 100%, specificity 42.3%) in girls in
the prepubertal period, and 5.22 (sensitivity 56%, 
specificity 93.3%) in boys and 3.82 (sensitivity 77.1%, 
specificity 71.4%) in girls in the pubertal period.  
Fasting insulin levels above 15 μU/mL in the prepubertal
period, 30 μU/mL in the pubertal period and 20 μU/mL in the
postpubertal period, FGIR above 6, 120-minute insulin >75
μU/mL during OGTT and peak insulin above 150 μIU/mL are
recommended as cut-off levels for hyperinsulinism and 
consequently as parameters showing insulin resistance
(5,28,29). High blood sugar values at minute 120 of OGTT is
an indicator of impaired glucose tolerance and therefore of 
insulin resistance (5). Each of these parameters (fasting 
insulin, insulin and blood sugar at 120th minute, FGIR and
HOMA-IR values) were compared using the ROC analysis 
regarding their importance in determination of 
insulin resistance according to pubertal status and gender 
(Figures 1, 2). With the exception of prepubertal girls, HOMA-
IR index was found to be the best determinant of insulin 
resistance in sub groups. On the other hand, insulin level at
120th minute was the best indicator of insulin resistance in
the prepubertal girls. Areas under the curves in the ROC
analysis of each indicator of insulin resistance according to
pubertal status and gender, and 95% confidence intervals
are given in Table 3.  
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Table 1. Findings in prepubertal boys and girls with and without hyperinsulinism
BOYS GIRLS
Hyperinsulinism  No hyperinsulinism P Hyperinsulinism  No hyperinsulinism                    P
PREPUBERTAL                       (n=17) (n=29) (n=10) (n=26)
Mean±SD Range Mean±SD Range Mean±SD Range Mean±SD Range
Age (years) 9.0±1.3 7-11 8.8±2.0 5.00-11.1 0.936 8.4±1.6 5-10 8.1±1.4 5.7-10 0.355 
BMI (kg/m2) 29.5±7.2 20.9-51.7 27.4±3.9 20.1-37.1 0.419 27.3±5.6 23.0-41.2 25.7±5.9 19.7-40.8 0.109
HOMA-IR 8.8±7.6 0.7-24.8 2.9±2.0 0.4-10.7 <0.001 5.0±2.1 2.3-37.5 3.3±2.1 0.7-8.2 0.034
Fasting insulin 42.0±36.6 4.2-118.7 14.7±9.6 2.2-51.0 0.001 25.3±9.0 12.0-37.5 17.1±11.0 3.4-44.0 0.026
(μU/mL)
120-min insulin 135.9±174.7 4.6-581 35.9±24.1 4.0-90.9 0.015 113.8±36.9 38.7-180.3 34.5±18.1 1.5-74.1 <0.001
(μU/mL)
Fasting blood  84.6±8.9 67.0-100.0 80.1±8.7 60.0-96.0 0.116 79.4±7.4 68-89 78.1±9.2          66.0-97.0 0.497
sugar (mg/dL) 
120-min blood  111.1±15.8 86.0-148.0 100.6±19.4     64-138 0.053 125.4±16.8 105.0-162.1     99.8±11.5 79.0-120.0 <0.001
sugar (mg/dL)
FGIR  4.1± 3.8 0.7-16.1 8.8±8.6 1.7-37.1 0.004 4.0±1.7 2.2-6.5 7.3±5.9 1.5-23.9 0.028
Total insulin  530.4±311.6 312.4-1333.2 159.4±71.1 18.4-298.6 <0.001 578.1±130.5 320.3-769.7 170.3±70.3 10.9-249.9          <0.001
(μU/mL)
BMI: Body mass index, HOMA-IR:Homeostasis model assessment for insulin resistance, FGIR: Fasting glucose/ insulin ratio, 
Range:Minimum-maximum values.Discussion
Obesity is a critical risk factor for the development of 
insulin resistance (30, 31). Total body fat is important in the
development of insulin resistance in children (30,32). Previous
studies have examined  the relationship between BMI and 
insulin sensitivity and have shown a strong negative correlation
between the values found with the euglycemic clamp test
and FSIVGTT and BMI (18, 33). In our study, no difference
was found in BMI values between groups with and without
insulin resistance, except for pubertal girls. This finding 
indicates that BMI values are not always correlated with
body fat ratio.  
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Table 2. Findings in pubertal boys and girls with and without hyperinsulinism
Boys                                                                                         Girls
Hyperinsulinism  No hyperinsulinism P Hyperinsulinism  No hyperinsulinism                    P
PUBERTAL                             (n=50) (n=31) (n=70) (n=35)
Mean±SD Range      Mean±SD Range Mean±SD Range Mean±SD Range
Age (years) 13.7±1.6 11.3-17.5 13.6±1.7 11.3-18.0 0.889 13.2±2.0 10.2-17.5 13.1±2.0 10.1-18.0 0.804
BMI (kg/m2) 30.8±4.6 21.9-41.9 31.1±5.3 24.6-46.5 0.817 31.1±5.3 22.5-49.3 28.9±4.4 22.6-43.0 0.043
HOMA-IR 7.2±4.6 1.3-19.1 3.4±1.7 0.8-7.9 <0.001 7.4±5.5 1.6-28.8 3.2±1.7 0.1-8.4 <0.001
Fasting insulin  35.3±21.6 7.9-91.5 18.1±9.3 4.2-40.2 <0.001 35.3±25.5 8.6-131.0 16.8±8.5 0.6-39.3 <0.001
(μU/mL)
120-min insulin  113.5±114.3 6.3-516.9 34.9±31.6 2.3-127.0 <0.001 126.5±132.5 7.6-858.2 39.2±28.5 1.5-129.4 <0.001
(μU/mL)
Fasting blood  82.0±10.1 64.0-106.0 77.2±12.1 42.0-97.0 0.054 83.9±11.2 61.0-122.0 76.9±9.0 54-97 0.002
sugar(mg/dL)
120-min blood  112.9±24.0 61.0-165 109.3±22.3 60.0-146.0 0.509 111.1±24.6 60.0-195.0 100.6±18.6 63.3-147 0.037
sugar(mg/dL)
FGIR 3.2±1.9 0.8-8.9 5.6±3.5 1.3-17.5 <0.001 3.3±1.7 0.6-9.0 8.5±16.1 2.2-98.2 0.064
Total insulin  600.0±38.1 309.7±2136 197.1±71.6 29.3-293.3 <0.001 655.0±490.0 302.0-3628.0 202.4±74.6 39.5-287.5 <0.001
(μU/mL)
BMI: Body mass index, HOMA-IR:Homeostasis model assessment for insulin resistance,
FGIR: Fasting glucose/ insulin ratio, Range: Minimum-maximum values
Table 3. Areas under the curves in the ROC analysis of each indicator of insulin resistance according to pubertal status and gender, and 95% 
confidence intervals.
Boys Girls
AUC 95% CI AUC 95% CI
HOMA-IR 0.800 0.653-0.904 0.729 0.550-0.866
Insulin 0th minute (μU/mL) 0.778 0.629-0.888 0.729 0.550-0.866
Insulin 120th minute (μU/mL) 0.698 0.543-0.826 0.954 0.821-0.994
Glucose 120th minute (mg/dL) 0.676 0.520-0.807 0.921 0.775-0.984
FGIR 0.739 0.587-0.858 0.725 0.545-0.863
HOMA-IR 0.784 0.673-0.865 0.836 0.748-0.903
Insulin 0th minute (μU/mL) 0.766 0.658-0.853 0.803 0.711-0.876
Insulin 120th minute (μU/mL) 0.784 0.678-0.868 0.798 0.705-0.872
Glucose 120th minute (mg/dL) 0.531 0.416-0.644 0.619 0.516-0.715
FGIR 0.745 0.635-0.836 0.535 0.432-0.636
AUC: Areas under the curves in the ROC analysis
FGIR: Fasting glucose/ insulin ratio
HOMA-IR: homeostasis model assessment for insulin resistance, CI: Confidence Interval
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lA transient insulin resistance develops in children during
puberty. This insulin resistance emerging during pubertal
maturation is accepted as a physiological condition rather
than pathologic (32,34). Decreased insulin sensitivity in the
pubertal period causes a compensatory increase in insulin
secretion  (20). Cross-sectional studies have shown that 
insulin resistance increases with the onset of puberty, 
makes a peak at Tanner stage 3 and recedes to prepubertal
levels at the end of puberty (15,16,18). Longitudinal studies
have found a 30% decrease in insulin sensitivity between
Tanner stages 1 and 5 (29). However, this decrease 
was found to return to normal at the end of puberty (35). The
reasons for these changes in insulin activation and secretion
are not fully understood, but are thought to be related to a
mechanism enhancing the anabolic effect of insulin and
growth hormone during rapid somatic growth (15,36). 
Although some studies have suggested that this change in
insulin sensitivity is due to the alterations in the pubertal 
distribution of fat, subsequent studies have shown similar 
decreases in insulin sensitivity both in thin and obese children
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Figure 1. Comparison of the parameters used in determination of insulin resistance with ROC analysis in prepubertal subjects
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Figure 2. Comparison of the parameters used in determination of insulin resistance with ROC analysis in pubertal subjects
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HOMA-IR: homeostasis model assessment for insulin resistance
FGIR: Fasting glucose/ insulin ratio(20, 37). Furthermore, it was shown that while body fat 
continuously increased before and during puberty, transient 
insulin elevation was seen in mid puberty with a return to 
normal levels at the end of puberty (16). Therefore, it is not
possible to explain insulin insensitivity with the change in fat
distribution only.
While type 2 diabetes was previously thought to occur in 
elderly adults,  it is now known that it also occurs in children
with an increased incidence of obesity. It is claimed that 
adolescence is a risky period for the development of type 2 
diabetes, because the transient physiological status in insulin
resistance induces an extra stress on the beta cells in the
pancreas (32). Therefore, adolescence is even more important
for obese children regarding the risk of developing type 2 
diabetes. In children of pubertal age, evaluation of insulin 
resistance as pathological or physiological and early 
intervention will help preserve the beta cell function of the
pancreas. Since both obesity and puberty have a role in the
development of insulin resistance, detection of increased 
insulin resistance of a pathological degree is of great 
importance, especially in obese adolescents. HOMA-IR 
cut-off values, which are among the most important 
indicators in determining insulin resistance in obese individuals,
are expected to be different in prepubertal and pubertal 
children. In our study, when the results were compared 
according to the pubertal status, HOMA-IR threshold values
were found to be significantly higher in the pubertal period
than before puberty, in both genders. Gender has also 
been shown to have an effect on insulin sensitivity. Moran
et al (16) reported greater insulin resistance in girls compared
to boys in a large group of 357 children with the euglycemic
clamp test even after adjusting for triceps and subcapsular skin
thickness, BMI, waist circumference and hip circumference.
Also, in a population-based study by Lee et al (38),  insulin
resistance was found to be greater in girls than in boys after
adjusting for weight, race and race/ethnicity. 
In our study, while no difference for gender was detected
in HOMA-IR cut-off values in the prepubertal period, cut-off
values in the pubertal period were higher in boys than in
girls. Because insulin resistance is greater in girls, HOMA-IR
cut-off values are expected to be lower in boys. We do not
have an explanation for this gender differences. However, it
is important that, in the evaluation of insulin resistance in the
pubertal period, different threshold values should be used
for boys and  girls.  
Moran et al (16) reported that gender differences for insulin
resistance disappeared among children with BMI values
greater than 27 kg/m2 and therefore, gender difference can
become insignificant in morbid obesity. In our study, no 
difference between genders was observed despite the 
mean BMI values around 30 kg/m2 in all children.  
Due to the fact that our sample size was small , we are
not able to propose precise cut-off limits based on the 
results of this study. However, based on this experience, we
believe that determination of fasting glucose and insulin 
levels in epidemiological studies will provide much more 
accurate results with which we can calculate HOMA-IR. 
Another  weak point of this study is that we have not 
performed a clamp study, which is the gold standard. Thirdly,
we have taken the same criteria for insulin resistance in 
pre-and pubertal children on OGTT. However, there are
noestablished separate values for these periods.   
In conclusion, obesity and puberty are important factors
for the development of insulin resistance. Both gender 
and pubertal status should be considered when evaluating
insulin resistance in obese children, and risk groups should
be identified accordingly. Gender differences should also be
considered in the evaluation of insulin resistance. We 
recommend that HOMA-IR cut-off values, which are among
the most widely used indicators of insulin resistance, 
be used in this evaluation, also taking into account both 
pubertal status and gender differences. Thus, particularly in
a period critical for the development of type 2 diabetes such
as the pubertal period, risk groups can be determined in a
more reliable manner, and measures can be taken.   
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